Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Marc Steven Hanover Insider Profile
4 Followers
Marc Steven Hanover, CEO, Director at Oncternal Therapeutics, holds 172.05K shares in Oncternal Therapeutics (Ticker: ONCT). Most recently, Marc Steven Hanover Sold $7,309 shares of Oncternal Therapeutics on Jan 09, 2018 for an estimated value of 82.85K.
Marc Steven Hanover Oncternal Therapeutics (ONCT)CEO, Director
Oncternal Therapeutics (ONCT)
CEO, Director
Ranked #17,639 out of 97,997 Corporate Insiders
Profitable Transactions
5 out of 11 Profitable Transactions
Average Return
+8.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Marc Steven Hanover's holdings
Insider Roles
CEO, Director
Roles that Marc Steven Hanover holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jan 09, 2018 - Jan 09, 2019
Return:+90.80%
The most profitable trade made by Marc Steven Hanover
Marc Steven Hanover's Trading History
List of latest transactions for each holding click on a transaction to see Marc Steven Hanover's performance on stock
You May Also Like
Marc Steven Hanover insider profile FAQ
What is the percentage of profitable transactions made by Marc Steven Hanover?
The percentage of profitable transactions made by Marc Steven Hanover is 45%.
What is the average return per transaction made by Marc Steven Hanover?
The average return per transaction made by Marc Steven Hanover is 8.10%.
What stocks does Marc Steven Hanover hold?
Marc Steven Hanover holds: ONCT stocks.
What was Marc Steven Hanover’s latest transaction?
Marc Steven Hanover latest transaction was an Informative Sell of $82.85K.
What was Marc Steven Hanover's most profitable transaction?
Marc Steven Hanover’s most profitable transaction was an Informative Sell of ONCT stock on January 9, 2018. The return on the trade was 90.80%.
What is Marc Steven Hanover's role in Oncternal Therapeutics?
Marc Steven Hanover's role in Oncternal Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.